Provide an overview of the current use and potential of HTA as a component of clinical trials aimed at regulatory approval of novel agents in various medical fields
Introduce the general concept of HTA and cost-effectiveness in healthcare
Discuss how these aspects are becoming an important requirement for market access and how the relevant additional elements can be incorporated and collected in a phase III clinical trial
Illustrate the presentation with several examples, including clinical trials in which the authors have actively taken part as principal investigators and analysts
Make tentative conclusions about future directions and the impact of HTA data in the drug-development process
Incorporating Health Technology Assessment (HTA) in Clinical Trials to be held in Online, Canada between 22 February 2017 and 22 February 2017. It covers specific areas of Biology and life sciences such as . Visit the website of the conference for more detailed information or contact the organizer for specific questions.
Add to calendar2017-02-222017-02-22Europe/LondonIncorporating Health Technology Assessment (HTA) in Clinical Trialshttps://www.sciencedz.net/en/conference/24496-incorporating-health-technology-assessment-hta-in-clinical-trialsOnline - Canada
Disclaimer :
We aim to provide correct and reliable information about
upcoming events, but cannot accept responsibility for the text
of announcements or for the bona fides of event organizers.
Please feel free to contact us if you notice incorrect or
misleading information and we will attempt to correct it.We are not involved in the organization of any of the events listed and we do not handle registration payments on behalf of the organizers.
Subscribe Now
Subscribe to receive conference alerts and news.
Share this event
Embed this event in your webpage
Copy the text below and past it in your html code: